Cd86-KO 基因敲除小鼠

1. Van Coillie, Samya, Wiernicki, Bartosz, Xu, Jie. . Molecular and Cellular Functions of CTLA-4. In Advances in experimental medicine and biology, 1248, 7-32. doi:10.1007/978-981-15-3266-5_2. https://pubmed.ncbi.nlm.nih.gov/32185705/

2. Halliday, Neil, Williams, Cayman, Kennedy, Alan, Walker, Lucy S K, Sansom, David M. 2020. CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4. In Frontiers in immunology, 11, 600000. doi:10.3389/fimmu.2020.600000. https://pubmed.ncbi.nlm.nih.gov/33363541/

3. Wolf, Elise W, Howard, Zachary P, Duan, Lihui, Xu, Ying, Cyster, Jason G. 2022. GPR174 signals via Gαs to control a CD86-containing gene expression program in B cells. In Proceedings of the National Academy of Sciences of the United States of America, 119, e2201794119. doi:10.1073/pnas.2201794119. https://pubmed.ncbi.nlm.nih.gov/35639700/

4. Ando, Hanano, Katoh, Yuki, Kobayashi, Osamu, Schust, Danny J, Kawana, Kei. . Low CD86 expression is a predictive biomarker for clinical response to the therapeutic human papillomavirus vaccine IGMKK16E7: results of a post hoc analysis. In JNCI cancer spectrum, 8, . doi:10.1093/jncics/pkae091. https://pubmed.ncbi.nlm.nih.gov/39302712/